UBS Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$676K Sell
179,427
-1,420
-0.8% -$5.35K ﹤0.01% 4627
2025
Q1
$819K Sell
180,847
-47,408
-21% -$215K ﹤0.01% 4341
2024
Q4
$1.61M Buy
228,255
+124,922
+121% +$883K ﹤0.01% 3888
2024
Q3
$841K Sell
103,333
-6,366
-6% -$51.8K ﹤0.01% 3722
2024
Q2
$701K Sell
109,699
-42,289
-28% -$270K ﹤0.01% 3684
2024
Q1
$1.14M Buy
151,988
+50,833
+50% +$383K ﹤0.01% 3452
2023
Q4
$937K Buy
101,155
+36,244
+56% +$336K ﹤0.01% 3490
2023
Q3
$657K Buy
64,911
+22,611
+53% +$229K ﹤0.01% 3415
2023
Q2
$529K Buy
42,300
+17,036
+67% +$213K ﹤0.01% 3788
2023
Q1
$295K Buy
25,264
+542
+2% +$6.33K ﹤0.01% 4074
2022
Q4
$263K Buy
24,722
+18,597
+304% +$198K ﹤0.01% 4173
2022
Q3
$59K Buy
6,125
+2,801
+84% +$27K ﹤0.01% 5114
2022
Q2
$48K Sell
3,324
-20,021
-86% -$289K ﹤0.01% 4939
2022
Q1
$610K Sell
23,345
-22,437
-49% -$586K ﹤0.01% 3633
2021
Q4
$1.81M Buy
45,782
+30,388
+197% +$1.2M ﹤0.01% 2948
2021
Q3
$770K Buy
15,394
+5,683
+59% +$284K ﹤0.01% 3436
2021
Q2
$539K Sell
9,711
-21,021
-68% -$1.17M ﹤0.01% 3693
2021
Q1
$1.44M Sell
30,732
-2,402
-7% -$112K ﹤0.01% 3036
2020
Q4
$1.44M Buy
33,134
+26,485
+398% +$1.15M ﹤0.01% 2884
2020
Q3
$244K Sell
6,649
-804
-11% -$29.5K ﹤0.01% 3876
2020
Q2
$218K Sell
7,453
-10,722
-59% -$314K ﹤0.01% 3958
2020
Q1
$476K Sell
18,175
-1,011
-5% -$26.5K ﹤0.01% 3249
2019
Q4
$666K Sell
19,186
-10,949
-36% -$380K ﹤0.01% 3663
2019
Q3
$954K Buy
+30,135
New +$954K ﹤0.01% 3226